MetaCap

BioLineRx (BLRX) vs CalciMedica (CALC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

BioLineRx (BLRX) has outperformed CalciMedica (CALC) over the past year, losing 50.3% versus a loss of 91.3%. BioLineRx is the larger company by market cap ($10.9 million vs $9.4 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BLRX-50.34%CALC-91.27%
+108%+4%-101%
Oct 7, 20251 yearOct 7, 2026
BLRX-96.81%CALC-94.12%
+41%-31%-103%
Jun 12, 20235 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BLRX versus CALC key metrics
MetricBLRXCALC
Share price$2.19$1.37
Market cap$10.89M$9.35M
1-day change-0.82%-7.51%
YTD return-20.40%-95.51%
1-year return-50.34%-91.27%
5-year return-98.20%—
EPS (TTM)$0.00$-6.85
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$4.50$36.00
52-week low$2.15$1.33
Distance from 52-week high-51.40%-96.19%
Average volume16.27K73.03K
Shares outstanding4.98M6.83M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BLRX has outperformed CALC by 40.9 percentage points over the past year.

BLRX vs CALC FAQ

Which is bigger, BioLineRx or CalciMedica?

BioLineRx (BLRX) is larger, with a market capitalization of $10.89M compared with $9.35M for CalciMedica (CALC).

Which stock has performed better over the past year, BLRX or CALC?

BLRX returned -50.34% over the past 12 months, compared with -91.27% for CALC (price return, excluding dividends). Past performance does not predict future results.

Are BioLineRx and CalciMedica in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons